Biostage, Inc. (BSTG)
Biostage has a market cap or net worth of $68.70 million. The enterprise value is $65.82 million.
The next earnings date is Tuesday, March 28, 2023, after market close.
|Estimated Earnings Date||Mar 28, 2023|
Biostage has 11.64 million shares outstanding. The number of shares has increased by 15.99% in one year.
|Shares Change (YoY)||+15.99%|
|Shares Change (QoQ)||+3.43%|
|Owned by Insiders (%)||50.96%|
|Owned by Institutions (%)||n/a|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.04.
|Debt / Equity||0.04|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -47.80%.
|Return on Equity (ROE)||-47.80%|
|Return on Assets (ROA)||-28.85%|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.88M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +36.47% in the last 52 weeks. The beta is -0.93, so Biostage's price volatility has been lower than the market average.
|52-Week Price Change||+36.47%|
|50-Day Moving Average||6.02|
|200-Day Moving Average||5.90|
|Average Volume (30 Days)||1,380|
Short Selling Information
The latest short interest is 121,658, so 1.04% of the outstanding shares have been sold short.
|Short Previous Month||201,811|
|Short % of Shares Out||1.04%|
|Short % of Float||2.35%|
|Short Ratio (days to cover)||3.35|
|Earnings Per Share (EPS)||-$1.09|
The company has $2.97 million in cash and $88,000 in debt, giving a net cash position of $2.88 million or $0.25 per share.
|Cash & Cash Equivalents||2.97M|
|Net Cash Per Share||$0.25|
|Equity / Book Value||2.21M|
|Book Value Per Share||0.19|
In the last 12 months, operating cash flow was -$3.37 million and capital expenditures -$8,000, giving a free cash flow of -$3.38 million.
|Operating Cash Flow||-3.37M|
|Free Cash Flow||-3.38M|
|FCF Per Share||-$0.30|
Dividends & Yields
Biostage does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on December 22, 2017. It was a reverse split with a ratio of 1:20.
|Last Split Date||Dec 22, 2017|